RET and thyroid gland carcinoma: In the Original Investigation titled “Medullary Thyroid Cancer Risk and Mortality in Carriers of Incidentally Identified MEN2A RET Variants,”1 published June 27, 2025, there were errors in the number at risk tables of panels B and C of Figure 1.